腰仙部神経根痛の世界市場レポート2025年

腰仙部神経根痛市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は5.8％で、12億1,000万米ドルに成長します。予測期間における成長の背景には、疼痛管理技術の進歩、非オピオイド治療への重点化、脊椎研究開発への投資の増加、外来・低侵襲治療への需要の高まり、新興市場におけるヘルスケアへのアクセス向上などがあります。この期間に予想される主な動向には、低侵襲手術手技の進歩、標的抗炎症薬の開発、装着型疼痛管理装置の革新、神経根を特定するための高度な画像診断法、患者固有のデータに基づく個別化治療計画の作成などがあります。

退行性脊髄疾患の有病率の上昇は、今後数年間の腰仙部神経根痛市場の成長を促進すると予想されます。退行性脊椎疾患は、時間の経過に伴う脊椎の進行性劣化に起因するさまざまな障害を包含します。この増加の主な要因は、脊椎の変性と神経圧迫の原因となる高齢化人口とライフスタイル要因であり、効果的な診断と治療に対する需要の高まりにつながっています。腰仙部神経根痛は、神経根の刺激や圧迫を強調することで、根本的な脊柱変性問題の指標となり、臨床評価や治療計画を助けます。例えば、2023年5月、オーストラリアの公立大学シドニー大学は、2050年までに全世界で8億人以上が腰痛を経験すると予測しました。その結果、退行性脊椎疾患の発生率が高まることが、腰仙部神経根痛市場の拡大を後押しする重要な要因となっています。

腰仙部神経根痛市場の主要企業は、疼痛緩和と患者の快適性向上のため、小型で充電可能な脊髄刺激（SCS）システムを含む先進的な低侵襲神経調節療法の開発を優先しています。これらの小型化されたSCS装置は移植可能で、脊髄に電気インパルスを供給して痛みの信号を破壊し、バッテリー寿命の延長と低侵襲治療の選択肢を提供します。例えば、2022年12月、米国のヘルスケア企業であるアボット・ラボラトリーズは、慢性疼痛管理のための高度なBurstDR療法を提供するように設計されたEterna脊髄刺激システムを発表しました。このシステムは最先端の充電式バッテリー技術を採用しており、充電間隔を大幅に長くして患者の不便さを軽減しています。また、より効果的で持続的な疼痛緩和のために、自然な神経活動を再現するBurstDRなどの独自の刺激パターンが含まれています。さらに、この装置はMRIに対応しており、患者は装置を取り外すことなく安全に全身スキャンを受けることができます。また、アップグレードしやすい設計であるため、患者はさらなる手術を必要とすることなく、将来の技術改良にアクセスすることができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の腰仙部神経根痛：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腰仙部神経根痛市場：成長率分析
• 世界の腰仙部神経根痛市場の実績：規模と成長, 2019-2024
• 世界の腰仙部神経根痛市場の予測：規模と成長, 2024-2029, 2034F
• 世界の腰仙部神経根痛：総潜在市場規模（TAM）

第6章 市場セグメンテーション

• 世界の腰仙部神経根痛市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬物治療
• 非薬物治療
• 介入手順
• 世界の腰仙部神経根痛市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オーラル
• トピック
• 注射剤
• 埋め込み型
• 世界の腰仙部神経根痛市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の腰仙部神経根痛市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• リハビリテーションセンター
• 在宅ケア設定
• 世界の腰仙部神経根痛市場、薬物治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非ステロイド性抗炎症薬
• オピオイド
• 抗けいれん薬
• 抗うつ薬
• 筋弛緩剤
• コルチコステロイド
• 世界の腰仙部神経根痛市場、非薬物治療のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 理学療法
• 運動とリハビリテーションプログラム
• カイロプラクティックケア
• 鍼
• 認知行動療法
• 温熱療法と冷却療法
• 世界の腰仙部神経根痛市場介入処置の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 硬膜外ステロイド注射
• 高周波アブレーション
• 神経根ブロック
• 脊髄刺激療法
• 低侵襲減圧術
• 脊髄内ドラッグデリバリーシステム

第7章 地域別・国別分析

• 世界の腰仙部神経根痛市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腰仙部神経根痛市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腰仙部神経根痛市場：競合情勢
• 腰仙部神経根痛市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Eli Lilly and Company
• Boston Scientific Corporation
• Vertex Pharmaceuticals
• Biotronik
• Nevro Corp.
• Sorrento Therapeutics
• Scilex Holding Company
• ProMed Pharma
• SPR Therapeutics
• Saluda Medical Pty Ltd.
• Eliem Therapeutics
• Cephalon Inc.
• Semnur Pharmaceuticals Inc.
• Nalu Medical Inc.
• Sollis Therapeutics Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腰仙部神経根痛市場2029：新たな機会を提供する国
• 腰仙部神経根痛市場2029：新たな機会を提供するセグメント
• 腰仙部神経根痛市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Lumbosacral radicular pain is a type of pain that begins in the lower spine (lumbar and sacral areas) and travels along the course of a spinal nerve into the leg. It is most often caused by compression or irritation of the nerve root, typically resulting from conditions like a herniated disc or spinal stenosis.

The primary categories of treatment for lumbosacral radicular pain include pharmacological therapies, non-pharmacological approaches, and interventional procedures. Pharmacological therapies involve the use of drugs or medications to diagnose, manage, or prevent health conditions. These medications can be administered through various methods, including oral, topical, injectable, and implantable routes. The distribution of these drugs occurs through different channels such as hospital pharmacies, retail pharmacies, and online pharmacies, serving a range of end-users including hospitals, specialty clinics, rehabilitation centers, and homecare environments.

The lumbosacral radicular pain market research report is one of a series of new reports from The Business Research Company that provides lumbosacral radicular pain market statistics, including the lumbosacral radicular pain industry global market size, regional shares, competitors with the lumbosacral radicular pain market share, detailed lumbosacral radicular pain market segments, market trends, and opportunities, and any further data you may need to thrive in the lumbosacral radicular pain industry. This lumbosacral radicular pain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lumbosacral radicular pain market size has grown strongly in recent years. It will grow from $0.91 billion in 2024 to $0.97 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be credited to the rising prevalence of lower back disorders, a growing elderly population experiencing spinal problems, an increase in sedentary lifestyles and poor posture, heightened demand for pain management treatments, and greater awareness regarding early diagnosis and intervention.

The lumbosacral radicular pain market size is expected to see strong growth in the next few years. It will grow to $1.21 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The projected growth in the forecast period can be attributed to advancements in pain management technologies, a growing emphasis on non-opioid treatment alternatives, increased investment in spinal research and development, rising demand for outpatient and minimally invasive procedures, and improved access to healthcare in emerging markets. Key trends expected during this period include progress in minimally invasive surgical techniques, the development of targeted anti-inflammatory medications, innovations in wearable pain management devices, advanced imaging methods for identifying nerve roots, and the creation of personalized treatment plans based on patient-specific data.

The rising prevalence of degenerative spinal conditions is anticipated to drive the growth of the lumbosacral radicular pain market in the coming years. Degenerative spinal conditions encompass a range of disorders resulting from the progressive deterioration of the spine over time. This increase is primarily driven by aging populations and lifestyle factors that contribute to spinal degeneration and nerve compression, leading to greater demand for effective diagnosis and treatment. Lumbosacral radicular pain serves as an indicator of underlying degenerative spinal issues by highlighting nerve root irritation or compression, thereby aiding clinical assessment and treatment planning. For example, in May 2023, the University of Sydney, an Australia-based public university, projected that over 800 million people globally will experience back pain by 2050. As a result, the growing incidence of degenerative spinal conditions is a key factor fueling the expansion of the lumbosacral radicular pain market.

Leading companies in the lumbosacral radicular pain market are prioritizing the development of advanced minimally invasive neuromodulation therapies, including compact and rechargeable spinal cord stimulation (SCS) systems, to improve pain relief and enhance patient comfort. These miniaturized SCS devices are implantable and deliver electrical impulses to the spinal cord to disrupt pain signals, providing extended battery life and less invasive treatment options. For example, in December 2022, Abbott Laboratories, a U.S.-based healthcare company, introduced the Eterna spinal cord stimulation system designed to deliver advanced BurstDR therapy for chronic pain management. This system features state-of-the-art rechargeable battery technology that significantly lengthens the time between recharges, reducing inconvenience for patients. It also includes proprietary stimulation patterns, such as BurstDR, that replicate natural nerve activity for more effective and sustained pain relief. Additionally, the device is MRI-compatible, allowing patients to safely undergo full-body scans without device removal. Its design is also upgrade-friendly, enabling patients to access future technological improvements without requiring further surgeries.

In October 2024, Stryker Corporation, a U.S.-based medical technology company, acquired Vertos Medical Inc. for an undisclosed sum. This acquisition is intended to bolster Stryker's portfolio of minimally invasive spine treatments by incorporating Vertos Medical's innovative technologies, improving patient outcomes, and reinforcing its position as a leader in the spinal health market. Vertos Medical Inc. is a U.S.-based company focused on minimally invasive treatments for lumbar spinal stenosis (LSS).

Major players in the lumbosacral radicular pain market are Pfizer Inc., Johnson & Johnson Services Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Eli Lilly and Company, Boston Scientific Corporation, Vertex Pharmaceuticals, Biotronik, Nevro Corp., Sorrento Therapeutics, Scilex Holding Company, ProMed Pharma, SPR Therapeutics, Saluda Medical Pty Ltd., Eliem Therapeutics, Cephalon Inc., Semnur Pharmaceuticals Inc., Nalu Medical Inc., Sollis Therapeutics Inc.

North America was the largest region in the lumbosacral radicular pain market in 2024. The regions covered in lumbosacral radicular pain report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lumbosacral radicular pain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lumbosacral radicular pain market includes revenues earned by entities by providing services such as non-surgical treatment services, interventional pain management services, and rehabilitation and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lumbosacral Radicular Pain Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lumbosacral radicular pain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lumbosacral radicular pain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lumbosacral radicular pain market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Pharmacological Treatment; Non-Pharmacological Treatment; Interventional Procedures
• 2) By Route Of Administration: Oral; Topical; Injectable; Implantable
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
• 4) By End User: Hospitals; Specialty Clinics; Rehabilitation Centers; Homecare Settings
• Subsegments:
• 1) By Pharmacological Treatment: Nonsteroidal Anti-Inflammatory Drugs; Opioids; Anticonvulsants; Antidepressants; Muscle Relaxants; Corticosteroids
• 2) By Non-Pharmacological Treatment: Physical Therapy; Exercise And Rehabilitation Programs; Chiropractic Care; Acupuncture; Cognitive Behavioral Therapy; Heat And Cold Therapy
• 3) By Interventional Procedures: Epidural Steroid Injections; Radiofrequency Ablation; Nerve Root Blocks; Spinal Cord Stimulation; Minimally Invasive Decompression; Intrathecal Drug Delivery Systems
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Abbott Laboratories; Novartis AG; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lumbosacral Radicular Pain Market Characteristics

3. Lumbosacral Radicular Pain Market Trends And Strategies

4. Lumbosacral Radicular Pain Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lumbosacral Radicular Pain Growth Analysis And Strategic Analysis Framework

• 5.1. Global Lumbosacral Radicular Pain PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Lumbosacral Radicular Pain Market Growth Rate Analysis
• 5.4. Global Lumbosacral Radicular Pain Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Lumbosacral Radicular Pain Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Lumbosacral Radicular Pain Total Addressable Market (TAM)

6. Lumbosacral Radicular Pain Market Segmentation

• 6.1. Global Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Treatment
• Non-Pharmacological Treatment
• Interventional Procedures
• 6.2. Global Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Injectable
• Implantable
• 6.3. Global Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• 6.4. Global Lumbosacral Radicular Pain Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Rehabilitation Centers
• Homecare Settings
• 6.5. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Pharmacological Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nonsteroidal Anti-Inflammatory Drugs
• Opioids
• Anticonvulsants
• Antidepressants
• Muscle Relaxants
• Corticosteroids
• 6.6. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Non-Pharmacological Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Exercise And Rehabilitation Programs
• Chiropractic Care
• Acupuncture
• Cognitive Behavioral Therapy
• Heat And Cold Therapy
• 6.7. Global Lumbosacral Radicular Pain Market, Sub-Segmentation Of Interventional Procedures, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Epidural Steroid Injections
• Radiofrequency Ablation
• Nerve Root Blocks
• Spinal Cord Stimulation
• Minimally Invasive Decompression
• Intrathecal Drug Delivery Systems

7. Lumbosacral Radicular Pain Market Regional And Country Analysis

• 7.1. Global Lumbosacral Radicular Pain Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Lumbosacral Radicular Pain Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lumbosacral Radicular Pain Market

• 8.1. Asia-Pacific Lumbosacral Radicular Pain Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lumbosacral Radicular Pain Market

• 9.1. China Lumbosacral Radicular Pain Market Overview
• 9.2. China Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lumbosacral Radicular Pain Market

• 10.1. India Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lumbosacral Radicular Pain Market

• 11.1. Japan Lumbosacral Radicular Pain Market Overview
• 11.2. Japan Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lumbosacral Radicular Pain Market

• 12.1. Australia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lumbosacral Radicular Pain Market

• 13.1. Indonesia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lumbosacral Radicular Pain Market

• 14.1. South Korea Lumbosacral Radicular Pain Market Overview
• 14.2. South Korea Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lumbosacral Radicular Pain Market

• 15.1. Western Europe Lumbosacral Radicular Pain Market Overview
• 15.2. Western Europe Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lumbosacral Radicular Pain Market

• 16.1. UK Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lumbosacral Radicular Pain Market

• 17.1. Germany Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lumbosacral Radicular Pain Market

• 18.1. France Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lumbosacral Radicular Pain Market

• 19.1. Italy Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lumbosacral Radicular Pain Market

• 20.1. Spain Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lumbosacral Radicular Pain Market

• 21.1. Eastern Europe Lumbosacral Radicular Pain Market Overview
• 21.2. Eastern Europe Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lumbosacral Radicular Pain Market

• 22.1. Russia Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lumbosacral Radicular Pain Market

• 23.1. North America Lumbosacral Radicular Pain Market Overview
• 23.2. North America Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lumbosacral Radicular Pain Market

• 24.1. USA Lumbosacral Radicular Pain Market Overview
• 24.2. USA Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lumbosacral Radicular Pain Market

• 25.1. Canada Lumbosacral Radicular Pain Market Overview
• 25.2. Canada Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lumbosacral Radicular Pain Market

• 26.1. South America Lumbosacral Radicular Pain Market Overview
• 26.2. South America Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lumbosacral Radicular Pain Market

• 27.1. Brazil Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lumbosacral Radicular Pain Market

• 28.1. Middle East Lumbosacral Radicular Pain Market Overview
• 28.2. Middle East Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lumbosacral Radicular Pain Market

• 29.1. Africa Lumbosacral Radicular Pain Market Overview
• 29.2. Africa Lumbosacral Radicular Pain Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Lumbosacral Radicular Pain Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Lumbosacral Radicular Pain Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lumbosacral Radicular Pain Market Competitive Landscape And Company Profiles

• 30.1. Lumbosacral Radicular Pain Market Competitive Landscape
• 30.2. Lumbosacral Radicular Pain Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

31. Lumbosacral Radicular Pain Market Other Major And Innovative Companies

• 31.1. Eli Lilly and Company
• 31.2. Boston Scientific Corporation
• 31.3. Vertex Pharmaceuticals
• 31.4. Biotronik
• 31.5. Nevro Corp.
• 31.6. Sorrento Therapeutics
• 31.7. Scilex Holding Company
• 31.8. ProMed Pharma
• 31.9. SPR Therapeutics
• 31.10. Saluda Medical Pty Ltd.
• 31.11. Eliem Therapeutics
• 31.12. Cephalon Inc.
• 31.13. Semnur Pharmaceuticals Inc.
• 31.14. Nalu Medical Inc.
• 31.15. Sollis Therapeutics Inc.

32. Global Lumbosacral Radicular Pain Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lumbosacral Radicular Pain Market

34. Recent Developments In The Lumbosacral Radicular Pain Market

35. Lumbosacral Radicular Pain Market High Potential Countries, Segments and Strategies

• 35.1 Lumbosacral Radicular Pain Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Lumbosacral Radicular Pain Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Lumbosacral Radicular Pain Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer